 |
|
NewYorkBIO News
November 2016
|
|
NewYorkBIO thanks our Sustaining Members
|
|
Notes from Nathan
Autumn is always a season of ideas and innovation in New York's life science community, and 2016 is no exception. This month, NewYorkBIO members have opportunities to participate in some uniquely valuable seminars and symposia designed to make the most of the current business and science atmosphere.
We here at NewYorkBIO are very excited about the third installment of our popular annual finance series, Who Needs a VC 3: New Models for Financing Life Science Companies. Looking at emerging funding models for the next generations of drugs and devices, we will explore the possibilities to fund early and emerging biomedical research. Our Finance Symposium will be held on November 15th at the offices of Frommer Lawrence & Haug, NYC.
And of course, this November, all eyes are focused on election day, so our NewYorkBIO Government Relations team will hold a special meeting to help us all make sense of the results and to create the plans the will best position our membership going forward. As well as the Presidential election, a host of federal, state and local races promise to impact New York life sciences. Join us for a special conference call and webinar on November 11th at 10AM.
While it is not precisely a symposium, our annual Holiday Celebration offers refreshment for both the spirit and the intellect, so mark December 13th on your calendars. This year, we will meet at the Alexandria Center for Life Sciences NYC, where we will enjoy networking and the Jazz saxophone stylings of Juilliard's Ruaridh Pattison.
I look forward to seeing you!
Nathan Tinker
|
Guest Contributor
VWR - Making it Easier to do Business with Us!
VWR is continually optimizing how you can do business with us. Through our combination of product choice, differentiated services, operational excellence and global presence - we align our goals to support your evolving business needs.
Searching for a product?
VWR's broad portfolio, combined with robust cross-referencing and cost-savings tools, quickly directs you to your desired product. If you are unable to find what you are looking for, VWR makes it easy to request the product with a simple on-line request form. Your request will be immediately routed to our sourcing partners, who will respond to you directly with price and availability. To get started with your request, please reach out to your local VWR Sales Representative.
Placing an order on vwr.com?
VWR offers updated order information, when you need it, delivered the way you want it! We'll tell you when your order ships and when there is a change to its estimated arrival date.
As an added benefit, you can choose how you would like to receive these notifications - either a daily consolidated email or an email per order. Advance ship notices will include a link to your tracking information and certificates. It's easy to get started!
Check out this video that shows you how easy it is to know where your order is and get instant access to all necessary documentation
.
Our focus is to deliver a seamless experience, allowing you to experience vwr.com in a new and more efficient way. We strive to meet your needs the first time, every time. It's the VWR Commitment to Enable Science.
Smooth Sailing for the Inaugural Buffalo BioCruise
Upstate life scientists enjoyed the opportunity to don resort wear and reconnect with
life science friends for a dinner cruise on Lake Erie. NewYorkBIO's Buffalo Bi
oCruise proved as popular as the annual summer edition in New York Harbor.
Sponsored by Johnson & Johnson Innovation and Pfizer, the Buffalo Biocruise featured cocktails, dinner, and spectacular views of the city and lake on a tour of Buffalo Harbor, Lake Erie, and the Erie Canal.
Passengers enjoyed live music thanks to Buffalo's hugely popular band, Toast
.
Executive Director of NewYorkBIO, Nathan Tinker, described the evening as a great success--sure to become an annual event, "We are
thrilled to offer this Lake cruise to the Buffalo area. We enjoyed a beautiful September evening on the Lake. Along with networking,
fine dining and live music, who could ask for more?"
Sold-Out CEO Breakfast Crowd Greets Nancy Thornberry of Kallyope
Top executives from New York life science community met last month in the historic Stanford White Room of Chef Geoffrey Zakarian's Lambs Club to hear Nancy Thornberry share her ideas on cutting-edge technologies and the gut-brain connection to innovative therapeutics. As this was the final meeting of the Breakfast Club for 2016, it was f
itting that Nancy Thornberry provided a dynamic,
insightful
perspective
on her experiences from biochemist to franchise Head at Merck to CEO of Kallyope.
Kallyope is developing an industry-leading platform to harness the gut-brain axis. The company's cross-disciplinary biotechnology team will integrate cutting-edge technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that will lead to transformational therapeutics and consumer products to improve human health and nutrition.
The Breakfast Club offers life science executives an opportunity to share ideas with about 25 peers in an intimate setting in the Stanford White Room at New York City's renowned Lamb's Club. This popular NewYorkBIO event attracts life science leaders in entrepreneurship and investment who discuss current issues and experiences as biotech leaders.
|
 New York Legislative Update
The General election includes a long list of federal, state, and local races that may have a significant impact on New York's life science industry. Among other important issues at stake is control of the NY State Senate.
NewYorkBIO Members are invited to join us for an important update, led by NewYorkBIO's government relations team, as we hold a conference call and webinar event on November 11, 2016, at the NewYorkBIO offices at 10:00AM.
Among other issues at stake:
- Presidential choice and its impact on FDA and other key agencies
- Party control of the New York State Senate
- Local congressional races across the state
Because of the importance of the topic, this event is FREE to both NewYorkBIO members and non-members. CLICK HERE TO REGISTER
Members in good standing are invited to join the NewYork Bio State Government Relations
Committee, which holds meetings on the second Friday of each month. For more information, visit our website.
|
Upcoming Events
Sunday, January 8, 2017
4:00 PM - 7:00 PM
NewYorkBIO Wine Reception @ JPMorgan Healthcare Conference
The Marker San Francisco, 501 Geary St, San Francisco CA 94102
Monday, February 13 - Tuesday, February 14, 2017
BIO CEO & Investor Conference
The Waldorf Astoria New York
|
Annual Holiday Celebration
Celebrate the holidays with friends and colleagues!
Join us for an evening of great wine, great food, great networking, and even a little entertainment.
December 13
6:00-9:00PM
Alexandria Center for Life Science
New York City
Sponsored by
|
|
Welcome New Members
Special welcome to our newest Sustaining Member
Advaxis, Inc.
Princeton, NJ
Alpha1 Biologics, LLC
Stony Brook, NY
Applied Biological Laboratories Inc.
Brooklyn, NY
Aurora BioPharma, Inc.
Cambridge, MA
Axitech, LLC
Holtsville, NY
Center For Aquatic Animal Research and Management
Wingdale, NY
Clarapath
New York, NY
Cox Biosciences LLC
New York, NY
Cyclops Research & Development, Inc.
New York, NY
DrinkSavvy Inc.
Brooklyn, NY
Garwood Medical Devices, LLC
Buffalo, NY
|
iCell Gene Therapeutics
Stony Brook, NY
Klus Pharma Inc. Biologics
Cranbury, NJ
Matritek, Inc.
New York, NY
Neurovation Labs, Inc.
New York, NY
OncGen Therapeutics
New York, NY
Quentis, Inc.
New York, NY
Raadysan Biotech Inc.
Fishkill, NY
SCINSPIRE Holding & Consulting GmbH
New York, NY
SkinAxis LLC
North Brunswick, NJ
Thymon, LLC
New York, NY
WRS Therapeutics
New York, NY
|
|
|
|
NewYorkBIO Member News
If you have news to share with our 20,000+ subscribers, please send notes or releases to
AbbVie Inc.
AbbVie
announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for the investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530) (G/P) for the treatment of patients with chronic hepatitis C virus.
Accelerator Corporation
Accelerator Corporation announced it has expanded operations with three new institution partners: CoMotion at the University of Washington, Fred Hutchinson Cancer Research Center and Oregon Health & Science University.
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. announced the appointment of Bernie Cunningham, Ph.D, to the position of Executive Director of Clinical Supply Chain and Logistics, and CMC Project Management.
Read More
Advaxis, Inc.
Advaxis
announced that it has received preliminary approval for a $2.7 million tax credit from the New Jersey Economic Development Authority's New Jersey Technology Business Tax Certificate Transfer program.
Read More
Albert Einstein College of Medicine
The National Institutes of Health has awarded two co-investigators at
Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.
Robert B. Catell of Garden City, chairman of the New York State Smart Grid Consortium in Manhattan and the Advanced Energy Research & Technology Center at Stony Brook University, has been appointed to the board of directors of Applied DNA Sciences Inc. in Stony Brook.
Read More
Astellas
Astellas Pharma US, Inc. announced
that Astellas and Ganymed's shareholders have entered into an agreement for Astellas to acquire Ganymed.
Read More
Berkshire Sterile Manufacturing, Inc.
Berkshire Sterile Manufacturing is implementing a cost-effective strategy using a flexible isolator-based sterile manufacturing system engineered by Fedegari.
Read More
Biogelx, Inc.
Biogelx has expanded from its base at BioCity Scotland to open a satellite office in New York.
Read More
Celgene Corporation
Celgene Corporation and Agios Pharmaceuticals, Inc. announced each company has entered into
collaboration agreements with Abbott.
Cellectis Inc.
Cellectis announced that the Company, along with its agricultural biotech subsidiary,
Calyxt, hosted the world's first dinner made with gene edited foods.
The dinner, held on Thursday, Oct. 20, 2016, in New York required a six-month preparation.
Cold Spring Harbor
Laboratory
A new tool called Multiplexed Analysis of Projections by Sequencing (MAPseq), from researchers in Cold Spring Harbor Laboratory, uses genetic "barcodes" instead of colors to investigate the path of the neurons.
Read More
Cornell University
Cornell researchers are developing and validating "FeverPhone," technology for point-of-care differential diagnosis of the six common causes of acute febrile illness.
Read More
Former UK Minister for Trade and Investment has joined Covington & Burling.
CUNY Graduate Center
The pioneering work of Professor
Eleanore T. Wurtzel
(GC/Lehman, Biology), whose research is at the forefront of plant science, is featured in a special issue of Science.
Read More
Efferent Labs, Inc.
Efferent Labs chosen to participate in Life-science accelerator program.
Read More
Eli Lilly and Company
Eli Lilly and Company announced
that Wael Fayad has been appointed Chairman, President, and Chief Executive Officer of the Company, effective as of September 21, 2016.
Read More
Garwood Medical Devices, LLC
University at Buffalo spinoff ZOETIC Pharmaceuticals and UB technology licensee Garwood Medical Devices are among the first 18 companies nationwide selected to present at the prestigious University Startups Demo Day.
Gilda's Club
Gilda's Club NYC will present its Heart of Gold Award to former NewYorkBIO chairman Robert J. Easton on November 10, 2016.
Read More
Harlem Biospace
Harlem Biospace is holding a Riverside Chat on Data & Healthcare on
Tuesday, November 15th at th
e
New York Blood Center.
Helen and Robert Appel Alzheimer's Disease Research Institute
The Appel Alzheimer's Disease Research Institute welcomed Dr. Anna G. Orr and Dr. Adam L. Orr in October.
Read More
HHMI/The Rockefeller University
Three HHMI investigators and two HHMI professors have been elected to membership in the National Academy of Medicine.
Read More
International AIDS Vaccine Initiative
The International AIDS Vaccine Initiative (IAVI) has recently been awarded two new grants by the Bill & Melinda Gates Foundation to expedite the development of promising AIDS vaccine candidates and other new biomedical HIV prevention tools.
Read More
Johnson & Johnson Innovation, LLC
Johnson & Johnson Innovation announced the creation of the Center for Device Innovation at Texas Medical Center.
Kallyope
Kallyope announced that it has appointed Ann E. Weber, Ph.D., to the position of Senior Vice President, Drug Discovery, and William J. Rieflin as an independent member of its Board of Directors.
Matritek, Inc.
MatriTek, Inc. announced the launch of commercial production of novel extracellular matrix (ECM) biomaterials for biomedical research.
Merck & Co Inc.
Merck announced that the U.S. Food and Drug Administration has approved KEYTRUDA® (pembrolizumab), for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors have high PD-L1 expression.
Read More
Neurovation Labs, Inc.
Neurovation Labs, Inc., a biotechnology company developing Post-traumatic Stress Disorder diagnostics and treatments, announced that it has successfully raised its seed funding round earlier this month
Read More
New York Genome Center
Weill Cornell Medicine and the New York Genome Center were awarded a federal grant from the National Cancer Institute to support a joint cancer genomics data center for the research and clinical interpretation of tumors.
Read More
New York Stem Cell Foundation
The New York Stem Cell Foundation announced
that Feng Zhang, PhD, is the 2016 recipient of the NYSCF - Robertson Stem Cell Prize for
his pioneering advances to edit human and plant genomes using CRISPR-Cas9.
Novomer
LLC
Saudi Aramco acquires breakthrough Converge® polyol technology from Novomer, Inc.
Read More
NYU Langone School of Medicine
cancer researcher
Dafna Bar-Sagi, PhD, has been named a recipient of the Outstanding Investigator Award, a highly prestigious honor presented by the National Cancer Institute (NCI).
Optologix, Inc. announced that the company was selected to participate in the 2016 class of Health Wildcatters, a nationally-ranked healthcare startup accelerator program in Dallas.
Read More
Pepper Hamilton LLP
Pepper Hamilton has been nominated for the Product Liability Firm of the Year award by LMG Life Sciences.
Read More
Pfizer
Pfizer
announced the successful completion of its acquisition of Medivation, Inc.
Read More
Phosplatin Therapeutics
Phosplatin Therapeutics shares announcement with Sciclone Pharmaceuticals on the launch of a combination clinical trial of PT-112 in Taiwan.
Read More
Regeneron
Regeneron Pharmaceuticals, Inc. and
Sanofi announced that the U.S. Food and Drug Administration has accepted for priority review the Biologics
License Application (BLA) for dupilumab for the treatment of adult patients
Roche
Roche
announced that the U.S. Food and Drug Administration approved TECENTRIQ® (atezolizumab) for the treatment of people with metastatic non-small cell lung cancer (NSCLC) who have disease progression during or following platinum-containing chemotherapy, and have progressed on an appropriate FDA-approved targeted therapy if their tumor has EGFR or ALK gene abnormalities.
Tonix Pharmaceuticals Holding Corp.
Toni Pharmaceuticals
announced the closing of its previously announced underwritten public offering.
University of Rochester Medical Center
UR Medicine
Heart and Vascular
celebrated 200 second chances with an Oct. 22 reunion of heart transplant recipients, generous families of organ donors and staff.
Read More
Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
announced that the U.S. Food and Drug Administration (FDA) approved ORKAMBI
®
(lumacaftor/ivacaftor) for use in children with cystic fibrosis (CF) ages 6 through 11 who have two copies of the F508del mutation.
Weill Cornell Graduate School of Medical Sciences
Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medicine announced that they have established a new drug discovery company called Bridge Medicines.
Read More
|
|
|
|
|
|
